Naveen Pemmaraju: I was deeply honored to be an invited speaker at the prestigious 2nd Myeloid Malignancies Workshop in NYC at, Mt Sinai School of Medicine

Naveen Pemmaraju posted on LinkedIn:

“Last week, I was deeply honored to be an invited speaker at the prestigious 2nd Myeloid Malignancies Workshop in NYC at, Mt Sinai School of Medicine, chaired by Ruben Mesa, Marina Kremyanskaya and John Mascarhenas.

I delivered my talk on “Current and Future Directions for Blastic Plasmacytoid Dendritic Cell Neoplasm” and we had a brilliant and  interactive Qs and As together. Thanks to the organizers for this major speaking opportunity to continue to raise awareness for BPDCN and Rare Blood Cancer Research.”

Source: Naveen Pemmaraju/LinkedIn

Naveen Pemmaraju is a Professor and Director of BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.

His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.

He has been named MDACC’s, Department of Leukemia, Inaugural Director of BPDCN Program, in 2020, which is one of the world’s most active BPDCN research programs. Dr. Pemmaraju is the recipient of the MDACC Gerald P. Bodey Award for Excellence in Education in 2020. He is a well-known social media influencer and advocate.